These antifibrotic effects are in consonance with other NAFLD/NASH studies where NR treatment prevented the abnormal expression of hepatic Col1α1 and reduced Masson’s trichome staining in liver sections [65,83]. The gene discussed is COL1A1; the disease is metabolic dysfunction-associated steatohepatitis.